New tool aims to predict chemo risks for seniors
NCT ID NCT00477958
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a geriatric assessment tool—looking at thinking, memory, daily activities, and emotional well-being—can predict serious side effects from chemotherapy in older adults with cancer. Over 1,000 patients completed questionnaires and cognitive tests before and after treatment. The goal is to help doctors tailor cancer care for seniors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better predict which older patients are at risk for serious side effects from chemotherapy, leading to more personalized treatment plans.
What could go wrong
This is an observational study, not a treatment trial. The assessment tool may not accurately predict toxicity, and results may not apply to all older patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Case Comprehensive Cancer Center
Cleveland, Ohio, 44106-5065, United States
-
Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center
Orange, California, 92868, United States
-
City of Hope Medical Center
Duarte, California, 91010-3000, United States
-
James P. Wilmot Cancer Center at University of Rochester Medical Center
Rochester, New York, 14642, United States
-
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065, United States
-
Tower Cancer Research Foundation
Beverly Hills, California, 90211, United States
-
Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157-1096, United States
-
Yale Cancer Center
New Haven, Connecticut, 06520-8028, United States